UTHR Competitors
United Therapeutics Corporation
$533.12
-$8.39(-1.55%)
71
Overall
80
Value
66
Tech
68
Quality
Market Cap
$22.87B
Volume
654.28K
52W Range
$409.07 - $609.35
Target Price
$645.50
UTHR competitors: LLY, GILD, TEVA, PFE, BAX. United Therapeutics Corporation is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.
UTHR Competitors Compared
| Company | Price | Market cap | EPS est. (current yr) | Dividend yield | MarketXLS Rank |
|---|---|---|---|---|---|
| LLY Eli Lilly and Company | $1257.03 | $1.18T | $36.19 | 0.53% | 69 |
| GILD Gilead Sciences, Inc. | $156.19 | $193.67B | $-0.47 | 2.08% | 76 |
| TEVA Teva Pharmaceutical Industries Limited | $41.50 | $48.36B | $1.94 | - | 72 |
| PFE Pfizer Inc. | $29.58 | $168.60B | $2.96 | 5.81% | 76 |
| BAX Baxter International Inc. | $25.28 | $13.07B | $2.04 | 0.16% | 62 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | UTHR | $533.12 | -1.5% | 654.28K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get United Therapeutics Corporation Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW